TPG, Fosun Snag Chinese Health Care Co. For $369M

Law360, New York (February 18, 2014, 5:20 PM EST) -- A group led by private equity firm TPG has nabbed Chindex International Inc., a Chinese health care provider publicly traded in the U.S., in a going-private deal worth $369 million, the company said Monday.

Under the terms of the transaction, TPG has joined forces with Shanghai Fosun Pharmaceutical Co. Ltd. and Chindex co-founder and CEO Roberta Lipson to buy the company’s outstanding shares for $19.50 per share in cash, according to a statement.

The offer represents a 17 percent premium over its 30-day weighted average trading...
To view the full article, register now.